Pimecrolimus Patent Expiration
Pimecrolimus was first introduced by Bausch Health Us Llc
Pimecrolimus Patents
Given below is the list of patents protecting Pimecrolimus, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Elidel |
US6423722 (Pediatric) | Crystalline macrolides and process for their preparation |
Dec 26, 2018
(Expired) | Bausch |
| Elidel | US6423722 | Crystalline macrolides and process for their preparation |
Jun 26, 2018
(Expired) | Bausch |
| Elidel |
US5912238 (Pediatric) | Heteroatoms-containing tricyclic compounds |
Dec 15, 2016
(Expired) | Bausch |
| Elidel | US5912238 | Heteroatoms-containing tricyclic compounds |
Jun 15, 2016
(Expired) | Bausch |
| Elidel |
US6352998 (Pediatric) | Pharmaceutical compositions |
Apr 26, 2016
(Expired) | Bausch |
| Elidel | US6352998 | Pharmaceutical compositions |
Oct 26, 2015
(Expired) | Bausch |
Pimecrolimus's Family Patents
Explore Our Curated Drug Screens
Pimecrolimus Generic API Manufacturers
Several generic applications have been filed for Pimecrolimus. The first generic version for Pimecrolimus was by Actavis Laboratories Ut Inc Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc and was approved on Dec 27, 2018. And the latest generic version is by Glenmark Pharmaceuticals Ltd and was approved on Aug 29, 2019.
Given below is the list of companies who have filed for Pimecrolimus generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS UT INC
Actavis Laboratories Ut Inc Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Pimecrolimus. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | cream | Prescription | TOPICAL | AB | Dec 27, 2018 |
2. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Pimecrolimus. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | cream | Prescription | TOPICAL | AB | Aug 29, 2019 |